>AT3G01280.1 |  VDAC1 (VOLTAGE DEPENDENT ANION CHANNEL 1) voltage-gated anion channel 
MVKGPGLYTEIGKKARDLLYKDHNSDQKFSITTFSPAGVAITSTGTKKGDLLLGDVAFQS 
RRKNITTDLKVCTDSTFLITATVDEAAPGLRSIFSFKVPDQNSGKVELQYLHEYAGISTS 
MGLTQNPTVNFSGVIGSNVLAVGTDVSFDTKSGNFTKINAGLSFTKEDLIASLTVNDKGD 
LLNASYYHIVNPLFNTAVGAEVSHKLSSKDSTITVGTQHSLDPLTSVKARVNSAGIASAL 
IQHEWKPKSFFTISGEVDTKSIDKSAKVGLALALKP*
>AT2G27550.1 |  ATC (ARABIDOPSIS THALIANA CENTRORADIALIS) phosphatidylethanolamine binding 
MARISSDPLMVGRVIGDVVDNCLQAVKMTVTYNSDKQVYNGHELFPSVVTYKPKVEVHGG 
DMRSFFTLVMTDPDVPGPSDPYLREHLHWIVTDIPGTTDVSFGKEIIGYEMPRPNIGIHR 
FVYLLFKQTRRGSVVSVPSYRDQFNTREFAHENDLGLPVAAVFFNCQRETAARRR*
>AT2G01250.1 |  60S ribosomal protein L7 (RPL7B) 
MVESKVVVPESVLKKRKREEEWALEKKQNVEAAKKKNAENRKLIFKRAEQYSKEYAEKEK 
ELISLKREAKLKGGFYVDPEAKLLFIIRIRGINAIDPKTKKILQLLRLRQIFNGVFLKVN 
KATMNMLRRVEPYVTYGFPNLKSVKELIYKRGYGKLNHQRIALTDNSIVEQALGKHGIIC 
TEDLIHEILTVGPHFKEANNFLWPFQLKAPLGGLKKKRNHYVEGGDAGNRENFINELIRR 
MN*
>AT2G01250.1 |  60S ribosomal protein L7 (RPL7B) 
MVESKVVVPESVLKKRKREEEWALEKKQNVEAAKKKNAENRKLIFKRAEQYSKEYAEKEK 
ELISLKREAKLKGGFYVDPEAKLLFIIRIRGINAIDPKTKKILQLLRLRQIFNGVFLKVN 
KATMNMLRRVEPYVTYGFPNLKSVKELIYKRGYGKLNHQRIALTDNSIVEQALGKHGIIC 
TEDLIHEILTVGPHFKEANNFLWPFQLKAPLGGLKKKRNHYVEGGDAGNRENFINELIRR 
MN*
>AT2G01250.2 |  60S ribosomal protein L7 (RPL7B) 
MVESKVVVPESVLKKRKREEEWALEKKQNVEAAKKKNAENRKLIFKRAEQYSKEYAEKEK 
ELISLKREAKLKGGFYVDPEAKLLFIIRIRGINAIDPKTKKILQLLRLRQIFNGVFLKVN 
KATMNMLRRVEPYVTYGFPNLKSVKELIYKRGYGKLNHQRIALTDNSIVEQPTTSFGHSS 
LRHH*
>AT2G01250.2 |  60S ribosomal protein L7 (RPL7B) 
MVESKVVVPESVLKKRKREEEWALEKKQNVEAAKKKNAENRKLIFKRAEQYSKEYAEKEK 
ELISLKREAKLKGGFYVDPEAKLLFIIRIRGINAIDPKTKKILQLLRLRQIFNGVFLKVN 
KATMNMLRRVEPYVTYGFPNLKSVKELIYKRGYGKLNHQRIALTDNSIVEQPTTSFGHSS 
LRHH*
>AT3G08710.1 |  ATH9 (thioredoxin H-type 9) 
MGSCVSKGKGDDDSVHNVEFSGGNVHLITTKESWDDKLAEADRDGKIVVANFSATWCGPC 
KIVAPFFIELSEKHSSLMFLLVDVDELSDFSSSWDIKATPTFFFLKNGQQIGKLVGANKP 
ELQKKVTSIIDSVPESPQRP*
>AT3G08710.1 |  ATH9 (thioredoxin H-type 9) 
MGSCVSKGKGDDDSVHNVEFSGGNVHLITTKESWDDKLAEADRDGKIVVANFSATWCGPC 
KIVAPFFIELSEKHSSLMFLLVDVDELSDFSSSWDIKATPTFFFLKNGQQIGKLVGANKP 
ELQKKVTSIIDSVPESPQRP*
>AT3G08710.2 |  ATH9 (thioredoxin H-type 9) 
MGSCVSKGKGDDDSVHNVEFSGGNVHLITTKESWDDKLAEADRDGKIVVANFSATWCGPC 
KIVAPFFIELSEKHSSLMFLLVDVDELSDFSSSWDIKATPTFFFLKNGQQIGKLVGANKP 
ELQKKVTSIIDSVPESPQRP*
>AT3G08710.2 |  ATH9 (thioredoxin H-type 9) 
MGSCVSKGKGDDDSVHNVEFSGGNVHLITTKESWDDKLAEADRDGKIVVANFSATWCGPC 
KIVAPFFIELSEKHSSLMFLLVDVDELSDFSSSWDIKATPTFFFLKNGQQIGKLVGANKP 
ELQKKVTSIIDSVPESPQRP*
>AT2G21540.1 |  SFH3 (SEC14-LIKE 3) phosphatidylinositol transporter 
MTDTMSAHMDRHNKLDYDGSEDEKKTKLCSLKKKAINASNKFKHSFTKRTRRNSRVMSVS 
IVDDIDLEELQAVDAFRQALILDELLPSKHDDHHMMLRFLRARKFDLEKAKQMWTDMIHW 
RKEFGVDTIMEDFDFKEIDEVLKYYPQGYHGVDKDGRPVYIERLGQVDATKLMQVTTIDR 
YVKYHVREFEKTFNIKLPACSIAAKKHIDQSTTILDVQGVGLKSFSKAARDLLQRIQKID 
SDNYPETLNRMFIINAGSGFRLLWSTVKSFLDPKTTAKIHVLGNKYQSKLLEIIDSNELP 
EFLGGNCTCADKGGCMRSDKGPWNDPDIFKMVQNGEGKCPRKTLSNIEEKTISVDENTTM 
KSDSFAKNKFDAENTKFIPMIDKTVNASTWPTNLHKSNYPEPEDLYSAVKPSQRRGGEGY 
LFGGVMSLVMGLMTVVRLTKNMPRKLTEAAIYGGEVDKAETTMVSNQEYMSMVKRMAELE 
EKCRSLDNQPAAFSPEKEQILTAALSRVDELELQLAQTKKTLEETMATQHVIMAYIDKKK 
KKKKFFGF*
>AT2G21540.1 |  SFH3 (SEC14-LIKE 3) phosphatidylinositol transporter 
MTDTMSAHMDRHNKLDYDGSEDEKKTKLCSLKKKAINASNKFKHSFTKRTRRNSRVMSVS 
IVDDIDLEELQAVDAFRQALILDELLPSKHDDHHMMLRFLRARKFDLEKAKQMWTDMIHW 
RKEFGVDTIMEDFDFKEIDEVLKYYPQGYHGVDKDGRPVYIERLGQVDATKLMQVTTIDR 
YVKYHVREFEKTFNIKLPACSIAAKKHIDQSTTILDVQGVGLKSFSKAARDLLQRIQKID 
SDNYPETLNRMFIINAGSGFRLLWSTVKSFLDPKTTAKIHVLGNKYQSKLLEIIDSNELP 
EFLGGNCTCADKGGCMRSDKGPWNDPDIFKMVQNGEGKCPRKTLSNIEEKTISVDENTTM 
KSDSFAKNKFDAENTKFIPMIDKTVNASTWPTNLHKSNYPEPEDLYSAVKPSQRRGGEGY 
LFGGVMSLVMGLMTVVRLTKNMPRKLTEAAIYGGEVDKAETTMVSNQEYMSMVKRMAELE 
EKCRSLDNQPAAFSPEKEQILTAALSRVDELELQLAQTKKTLEETMATQHVIMAYIDKKK 
KKKKFFGF*
>AT2G21540.2 |  SFH3 (SEC14-LIKE 3) phosphatidylinositol transporter 
MTDTMSAHMDRHNKLDYDGSEDEKKTKLCSLKKKAINASNKFKHSFTKRTRRNSRVMSVS 
IVDDIDLEELQAVDAFRQALILDELLPSKHDDHHMMLRFLRARKFDLEKAKQMWTDMIHW 
RKEFGVDTIMEDFDFKEIDEVLKYYPQGYHGVDKDGRPVYIERLGQVDATKLMQVTTIDR 
YVKYHVREFEKTFNIKLPACSIAAKKHIDQSTTILDVQGVGLKSFSKAARDLLQRIQKID 
SDNYPETLNRMFIINAGSGFRLLWSTVKSFLDPKTTAKIHVLGNKYQSKLLEIIDSNELP 
EFLGGNCTCADKGGCMRSDKGPWNDPDIFKMVQNGEGKCPRKTLSNIEEKTISVDENTTM 
KSDSFAKNKFDAENTKFIPMIDKTVNASTWPTNLHKSNYPEPEDLYSAVKPSQRRGGEGY 
LFGGVMSLVMGLMTVVRLTKNMPRKLTEAAIYGGEVDKAETTMVSNQEYMSMVKRMAELE 
EKCRSLDNQPAAFSPEKEQILTAALSRVDELELQLAQTKKTLEETMATQHVIMAYIDKKK 
KKKKFFGF*
>AT2G21540.2 |  SFH3 (SEC14-LIKE 3) phosphatidylinositol transporter 
MTDTMSAHMDRHNKLDYDGSEDEKKTKLCSLKKKAINASNKFKHSFTKRTRRNSRVMSVS 
IVDDIDLEELQAVDAFRQALILDELLPSKHDDHHMMLRFLRARKFDLEKAKQMWTDMIHW 
RKEFGVDTIMEDFDFKEIDEVLKYYPQGYHGVDKDGRPVYIERLGQVDATKLMQVTTIDR 
YVKYHVREFEKTFNIKLPACSIAAKKHIDQSTTILDVQGVGLKSFSKAARDLLQRIQKID 
SDNYPETLNRMFIINAGSGFRLLWSTVKSFLDPKTTAKIHVLGNKYQSKLLEIIDSNELP 
EFLGGNCTCADKGGCMRSDKGPWNDPDIFKMVQNGEGKCPRKTLSNIEEKTISVDENTTM 
KSDSFAKNKFDAENTKFIPMIDKTVNASTWPTNLHKSNYPEPEDLYSAVKPSQRRGGEGY 
LFGGVMSLVMGLMTVVRLTKNMPRKLTEAAIYGGEVDKAETTMVSNQEYMSMVKRMAELE 
EKCRSLDNQPAAFSPEKEQILTAALSRVDELELQLAQTKKTLEETMATQHVIMAYIDKKK 
KKKKFFGF*
>AT5G17310.1 |  UTP--glucose-1-phosphate uridylyltransferase putative / UDP-glucose pyrophosphorylase putative / UGPase putative 
MRYAVYSFFRFHFLFLFLCRSVIEVRDGLTFLDLIVIQIENLNNKYNCKVPLVLMNSFNT 
HDDTQKIVEKYTKSNVDIHTFNQSKYPRVVADEFVPWPSKGKTDKDGWYPPGHGDVFPSL 
MNSGKLDAFLSQGKEYVFIANSDNLGAIVDLKILKHLIQNKNEYCMEVTPKTLADVKGGT 
LISYEGKVQLLEIAQVPDEHVNEFKSIEKFKIFNTNNLWVNLKAIKKLVEADALKMEIIP 
NPKEVDGVKVLQLETAAGAAIRFFDNAIGVNVPRSRFLPVKATSDLLLVQSDLYTLVDGF 
VTRNKARTNPTNPAIELGPEFKKVASFLSRFKSIPSIVELDSLKVSGDVWFGSGVVLKGK 
VTVKANAGTKLEIPDNAVLENKDINGPEDL*
>AT5G17310.1 |  UTP--glucose-1-phosphate uridylyltransferase putative / UDP-glucose pyrophosphorylase putative / UGPase putative 
MRYAVYSFFRFHFLFLFLCRSVIEVRDGLTFLDLIVIQIENLNNKYNCKVPLVLMNSFNT 
HDDTQKIVEKYTKSNVDIHTFNQSKYPRVVADEFVPWPSKGKTDKDGWYPPGHGDVFPSL 
MNSGKLDAFLSQGKEYVFIANSDNLGAIVDLKILKHLIQNKNEYCMEVTPKTLADVKGGT 
LISYEGKVQLLEIAQVPDEHVNEFKSIEKFKIFNTNNLWVNLKAIKKLVEADALKMEIIP 
NPKEVDGVKVLQLETAAGAAIRFFDNAIGVNVPRSRFLPVKATSDLLLVQSDLYTLVDGF 
VTRNKARTNPTNPAIELGPEFKKVASFLSRFKSIPSIVELDSLKVSGDVWFGSGVVLKGK 
VTVKANAGTKLEIPDNAVLENKDINGPEDL*
>AT5G17310.2 |  UTP--glucose-1-phosphate uridylyltransferase putative / UDP-glucose pyrophosphorylase putative / UGPase putative 
MAATATEKLPQLKSAVDGLTEMSENEKSGFINLVSRYLSGEAQHIEWSKIQTPTDEIVVP 
YDKMANVSEDASETKYLLDKLVVLKLNGGLGTTMGCTGPKSVIEVRDGLTFLDLIVIQIE 
NLNNKYNCKVPLVLMNSFNTHDDTQKIVEKYTKSNVDIHTFNQSKYPRVVADEFVPWPSK 
GKTDKDGWYPPGHGDVFPSLMNSGKLDAFLSQGKEYVFIANSDNLGAIVDLKILKHLIQN 
KNEYCMEVTPKTLADVKGGTLISYEGKVQLLEIAQVPDEHVNEFKSIEKFKIFNTNNLWV 
NLKAIKKLVEADALKMEIIPNPKEVDGVKVLQLETAAGAAIRFFDNAIGVNVPRSRFLPV 
KATSDLLLVQSDLYTLVDGFVTRNKARTNPTNPAIELGPEFKKVASFLSRFKSIPSIVEL 
DSLKVSGDVWFGSGVVLKGKVTVKANAGTKLEIPDNAVLENKDINGPEDL*
>AT5G17310.2 |  UTP--glucose-1-phosphate uridylyltransferase putative / UDP-glucose pyrophosphorylase putative / UGPase putative 
MAATATEKLPQLKSAVDGLTEMSENEKSGFINLVSRYLSGEAQHIEWSKIQTPTDEIVVP 
YDKMANVSEDASETKYLLDKLVVLKLNGGLGTTMGCTGPKSVIEVRDGLTFLDLIVIQIE 
NLNNKYNCKVPLVLMNSFNTHDDTQKIVEKYTKSNVDIHTFNQSKYPRVVADEFVPWPSK 
GKTDKDGWYPPGHGDVFPSLMNSGKLDAFLSQGKEYVFIANSDNLGAIVDLKILKHLIQN 
KNEYCMEVTPKTLADVKGGTLISYEGKVQLLEIAQVPDEHVNEFKSIEKFKIFNTNNLWV 
NLKAIKKLVEADALKMEIIPNPKEVDGVKVLQLETAAGAAIRFFDNAIGVNVPRSRFLPV 
KATSDLLLVQSDLYTLVDGFVTRNKARTNPTNPAIELGPEFKKVASFLSRFKSIPSIVEL 
DSLKVSGDVWFGSGVVLKGKVTVKANAGTKLEIPDNAVLENKDINGPEDL*
>AT1G13320.1 |  PP2AA3 (PROTEIN PHOSPHATASE 2A SUBUNIT A3) binding / protein phosphatase type 2A regulator 
MSMVDEPLYPIAVLIDELKNDDIQRRLNSIKRLSIIARALGEERTRKELIPFLSENNDDD 
DEVLLAMAEELGGFILYVGGVEYAYVLLPPLETLSTVEETCVREKAVDSLCRIGAQMRES 
DLVEHFTPLAKRLSAGEWFTARVSACGIFHIAYPSAPDVLKTELRSIYGQLCQDDMPMVR 
RAAATNLGKFAATIESAHLKTDIMSMFEDLTQDDQDSVRLLAVEGCAALGKLLEPQDCVA 
HILPVIVNFSQDKSWRVRYMVANQLYELCEAVGPEPTRTDLVPAYARLLCDNEAEVRIAA 
AGKVTKFCRILNPELAIQHILPCVKELSSDSSQHVRSALASVIMGMAPVLGKDATIEHLL 
PIFLSLLKDEFPDVRLNIISKLDQVNQVIGIDLLSQSLLPAIVELAEDRHWRVRLAIIEY 
IPLLASQLGVGFFDEKLGALCMQWLQDKVHSIREAAANNLKRLAEEFGPEWAMQHIVPQV 
LEMINNPHYLYRMTILRAVSLLAPVMGSEITCSKLLPAVITASKDRVPNIKFNVAKMMQS 
LIPIVDQAVVENMIRPCLVELSEDPDVDVRYFANQALQSIDNVMMSS*
>AT1G13320.1 |  PP2AA3 (PROTEIN PHOSPHATASE 2A SUBUNIT A3) binding / protein phosphatase type 2A regulator 
MSMVDEPLYPIAVLIDELKNDDIQRRLNSIKRLSIIARALGEERTRKELIPFLSENNDDD 
DEVLLAMAEELGGFILYVGGVEYAYVLLPPLETLSTVEETCVREKAVDSLCRIGAQMRES 
DLVEHFTPLAKRLSAGEWFTARVSACGIFHIAYPSAPDVLKTELRSIYGQLCQDDMPMVR 
RAAATNLGKFAATIESAHLKTDIMSMFEDLTQDDQDSVRLLAVEGCAALGKLLEPQDCVA 
HILPVIVNFSQDKSWRVRYMVANQLYELCEAVGPEPTRTDLVPAYARLLCDNEAEVRIAA 
AGKVTKFCRILNPELAIQHILPCVKELSSDSSQHVRSALASVIMGMAPVLGKDATIEHLL 
PIFLSLLKDEFPDVRLNIISKLDQVNQVIGIDLLSQSLLPAIVELAEDRHWRVRLAIIEY 
IPLLASQLGVGFFDEKLGALCMQWLQDKVHSIREAAANNLKRLAEEFGPEWAMQHIVPQV 
LEMINNPHYLYRMTILRAVSLLAPVMGSEITCSKLLPAVITASKDRVPNIKFNVAKMMQS 
LIPIVDQAVVENMIRPCLVELSEDPDVDVRYFANQALQSIDNVMMSS*
>AT1G13320.2 |  PP2AA3 (PROTEIN PHOSPHATASE 2A SUBUNIT A3) binding / protein phosphatase type 2A regulator 
MSMVDEPLYPIAVLIDELKNDDIQRRLNSIKRLSIIARALGEERTRKELIPFLSENNDDD 
DEVLLAMAEELGGFILYVGGVEYAYVLLPPLETLSTVEETCVREKAVDSLCRIGAQMRES 
DLVEHFTPLAKRLSAGEWFTARVSACGIFHIAYPSAPDVLKTELRSIYGQLCQDDMPMVR 
RAAATNLGKFAATIESAHLKTDIMSMFEDLTQDDQDSVRLLAVEGCAALGKLLEPQDCVA 
HILPVIVNFSQDKSWRVRYMVANQLYELCEAVGPEPTRTDLVPAYARLLCDNEAEVRIAA 
AGKVTKFCRILNPELAIQHILPCVKELSSDSSQHVRSALASVIMGMAPVLGKDATIEHLL 
PIFLSLLKDEFPDVRLNIISKLDQVNQVIGIDLLSQSLLPAIVELAEDRHWRVRLAIIEY 
IPLLASQLGVGFFDEKLGALCMQWLQDKVHSIREAAANNLKRLAEEFGPEWAMQHIVPQV 
LEMINNPHYLYRMTILRAVSLLAPVMGSEITCSKLLPAVITASKDRQFQTSNLTWPK*
>AT1G13320.2 |  PP2AA3 (PROTEIN PHOSPHATASE 2A SUBUNIT A3) binding / protein phosphatase type 2A regulator 
MSMVDEPLYPIAVLIDELKNDDIQRRLNSIKRLSIIARALGEERTRKELIPFLSENNDDD 
DEVLLAMAEELGGFILYVGGVEYAYVLLPPLETLSTVEETCVREKAVDSLCRIGAQMRES 
DLVEHFTPLAKRLSAGEWFTARVSACGIFHIAYPSAPDVLKTELRSIYGQLCQDDMPMVR 
RAAATNLGKFAATIESAHLKTDIMSMFEDLTQDDQDSVRLLAVEGCAALGKLLEPQDCVA 
HILPVIVNFSQDKSWRVRYMVANQLYELCEAVGPEPTRTDLVPAYARLLCDNEAEVRIAA 
AGKVTKFCRILNPELAIQHILPCVKELSSDSSQHVRSALASVIMGMAPVLGKDATIEHLL 
PIFLSLLKDEFPDVRLNIISKLDQVNQVIGIDLLSQSLLPAIVELAEDRHWRVRLAIIEY 
IPLLASQLGVGFFDEKLGALCMQWLQDKVHSIREAAANNLKRLAEEFGPEWAMQHIVPQV 
LEMINNPHYLYRMTILRAVSLLAPVMGSEITCSKLLPAVITASKDRQFQTSNLTWPK*
>AT2G40290.1 |  eukaryotic translation initiation factor 2 subunit 1 putative / eIF-2A putative / eIF-2-alpha putative 
MASQTPNLECRMYEAKYPEVDMAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRI 
RSVSSLIKVGRIEPVMVLRVDKEKGYIDLSKRRVSEEDIQTCEERYNKSKLVHSIMRHVA 
ETLSIDLEDLYVNIGWPLYRRHGHAFEAFKILVTDPDSVLGPLTREIKEVGPDGQEVTKV 
VPAVTEEVKDALVKNIRRRMTPQPMKIRADIELKCFQFDGVVHIKEAMKNAEAAGNEDCP 
VKIKLVAPPLYVLTTQTLDKEQGIEILNKAIAACTETIETHKGKLVVKEGARAVSERDEK 
MLTEHMAKLRLDNEEMSGDEDSGDEEEDTGMGEVDLDAGAGIIE*
>AT2G40290.1 |  eukaryotic translation initiation factor 2 subunit 1 putative / eIF-2A putative / eIF-2-alpha putative 
MASQTPNLECRMYEAKYPEVDMAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRI 
RSVSSLIKVGRIEPVMVLRVDKEKGYIDLSKRRVSEEDIQTCEERYNKSKLVHSIMRHVA 
ETLSIDLEDLYVNIGWPLYRRHGHAFEAFKILVTDPDSVLGPLTREIKEVGPDGQEVTKV 
VPAVTEEVKDALVKNIRRRMTPQPMKIRADIELKCFQFDGVVHIKEAMKNAEAAGNEDCP 
VKIKLVAPPLYVLTTQTLDKEQGIEILNKAIAACTETIETHKGKLVVKEGARAVSERDEK 
MLTEHMAKLRLDNEEMSGDEDSGDEEEDTGMGEVDLDAGAGIIE*
>AT2G40290.1 |  eukaryotic translation initiation factor 2 subunit 1 putative / eIF-2A putative / eIF-2-alpha putative 
MASQTPNLECRMYEAKYPEVDMAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRI 
RSVSSLIKVGRIEPVMVLRVDKEKGYIDLSKRRVSEEDIQTCEERYNKSKLVHSIMRHVA 
ETLSIDLEDLYVNIGWPLYRRHGHAFEAFKILVTDPDSVLGPLTREIKEVGPDGQEVTKV 
VPAVTEEVKDALVKNIRRRMTPQPMKIRADIELKCFQFDGVVHIKEAMKNAEAAGNEDCP 
VKIKLVAPPLYVLTTQTLDKEQGIEILNKAIAACTETIETHKGKLVVKEGARAVSERDEK 
MLTEHMAKLRLDNEEMSGDEDSGDEEEDTGMGEVDLDAGAGIIE*
>AT2G40290.2 |  eukaryotic translation initiation factor 2 subunit 1 putative / eIF-2A putative / eIF-2-alpha putative 
MASQTPNLECRMYEAKYPEVDMAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRI 
RSVSSLIKVGRIEPVMVLRVDKEKGYIDLSKRRVSEEDIQTCEERYNKSKLVHSIMRHVA 
ETLSIDLEDLYVNIGWPLYRRHGHAFEAFKILVTDPDSVLGPLTREIKEVGPDGQEVTKV 
VPAVTEEVKDALVKNIRRRMTPQPMKIRADIELKCFQFDGVVHIKVVSLIRLSLTCEMNT 
L*
>AT2G40290.2 |  eukaryotic translation initiation factor 2 subunit 1 putative / eIF-2A putative / eIF-2-alpha putative 
MASQTPNLECRMYEAKYPEVDMAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRI 
RSVSSLIKVGRIEPVMVLRVDKEKGYIDLSKRRVSEEDIQTCEERYNKSKLVHSIMRHVA 
ETLSIDLEDLYVNIGWPLYRRHGHAFEAFKILVTDPDSVLGPLTREIKEVGPDGQEVTKV 
VPAVTEEVKDALVKNIRRRMTPQPMKIRADIELKCFQFDGVVHIKVVSLIRLSLTCEMNT 
L*
>AT2G40290.2 |  eukaryotic translation initiation factor 2 subunit 1 putative / eIF-2A putative / eIF-2-alpha putative 
MASQTPNLECRMYEAKYPEVDMAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRI 
RSVSSLIKVGRIEPVMVLRVDKEKGYIDLSKRRVSEEDIQTCEERYNKSKLVHSIMRHVA 
ETLSIDLEDLYVNIGWPLYRRHGHAFEAFKILVTDPDSVLGPLTREIKEVGPDGQEVTKV 
VPAVTEEVKDALVKNIRRRMTPQPMKIRADIELKCFQFDGVVHIKVVSLIRLSLTCEMNT 
L*
>AT2G40290.3 |  eukaryotic translation initiation factor 2 subunit 1 putative / eIF-2A putative / eIF-2-alpha putative 
MASQTPNLECRMYEAKYPEVDMAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRI 
RSVSSLIKVGRIEPVMVLRVDKEKGYIDLSKRRVSEEDIQTCEERYNKSKLVHSIMRHVA 
ETLSIDLEDLYVNIGWPLYRRHGHAFEAFKILVTDPDSVLGPLTREIKEVGPDGQEVTKV 
VPAVTEEVKDALVKNIRRRMTPQPMKIRADIELKCFQFDGVVHIKVVSLIRLSLTCEMNT 
L*
>AT2G40290.3 |  eukaryotic translation initiation factor 2 subunit 1 putative / eIF-2A putative / eIF-2-alpha putative 
MASQTPNLECRMYEAKYPEVDMAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRI 
RSVSSLIKVGRIEPVMVLRVDKEKGYIDLSKRRVSEEDIQTCEERYNKSKLVHSIMRHVA 
ETLSIDLEDLYVNIGWPLYRRHGHAFEAFKILVTDPDSVLGPLTREIKEVGPDGQEVTKV 
VPAVTEEVKDALVKNIRRRMTPQPMKIRADIELKCFQFDGVVHIKVVSLIRLSLTCEMNT 
L*
>AT2G40290.3 |  eukaryotic translation initiation factor 2 subunit 1 putative / eIF-2A putative / eIF-2-alpha putative 
MASQTPNLECRMYEAKYPEVDMAVMIQVKNIADMGAYVSLLEYNNIEGMILFSELSRRRI 
RSVSSLIKVGRIEPVMVLRVDKEKGYIDLSKRRVSEEDIQTCEERYNKSKLVHSIMRHVA 
ETLSIDLEDLYVNIGWPLYRRHGHAFEAFKILVTDPDSVLGPLTREIKEVGPDGQEVTKV 
VPAVTEEVKDALVKNIRRRMTPQPMKIRADIELKCFQFDGVVHIKVVSLIRLSLTCEMNT 
L*
>AT5G03840.1 |  TFL1 (TERMINAL FLOWER 1) phosphatidylethanolamine binding 
MENMGTRVIEPLIMGRVVGDVLDFFTPTTKMNVSYNKKQVSNGHELFPSSVSSKPRVEIH 
GGDLRSFFTLVMIDPDVPGPSDPFLKEHLHWIVTNIPGTTDATFGKEVVSYELPRPSIGI 
HRFVFVLFRQKQRRVIFPNIPSRDHFNTRKFAVEYDLGLPVAAVFFNAQRETAARKR*
>AT1G18100.1 |  E12A11 phosphatidylethanolamine binding 
MAASVDPLVVGRVIGDVLDMFIPTANMSVYFGPKHITNGCEIKPSTAVNPPKVNISGHSD 
ELYTLVMTDPDAPSPSEPNMREWVHWIVVDIPGGTNPSRGKEILPYMEPRPPVGIHRYIL 
VLFRQNSPVGLMVQQPPSRANFSTRMFAGHFDLGLPVATVYFNAQKEPASRRR*
>AT4G20370.1 |  TSF (TWIN SISTER OF FT) phosphatidylethanolamine binding 
MSLSRRDPLVVGSVVGDVLDPFTRLVSLKVTYGHREVTNGLDLRPSQVLNKPIVEIGGDD 
FRNFYTLVMVDPDVPSPSNPHQREYLHWLVTDIPATTGNAFGNEVVCYESPRPPSGIHRI 
VLVLFRQLGRQTVYAPGWRQQFNTREFAEIYNLGLPVAASYFNCQRENGCGGRRT*
>AT1G65480.1 |  FT (FLOWERING LOCUS T) phosphatidylethanolamine binding / protein binding 
MSINIRDPLIVSRVVGDVLDPFNRSITLKVTYGQREVTNGLDLRPSQVQNKPRVEIGGED 
LRNFYTLVMVDPDVPSPSNPHLREYLHWLVTDIPATTGTTFGNEIVCYENPSPTAGIHRV 
VFILFRQLGRQTVYAPGWRQNFNTREFAEIYNLGLPVAAVFYNCQRESGCGGRRL*
>AT5G62040.1 |  brother of FT and TFL1 protein (BFT) 
MSREIEPLIVGRVIGDVLEMFNPSVTMRVTFNSNTIVSNGHELAPSLLLSKPRVEIGGQD 
LRSFFTLIMMDPDAPSPSNPYMREYLHWMVTDIPGTTDASFGREIVRYETPKPVAGIHRY 
VFALFKQRGRQAVKAAPETRECFNTNAFSSYFGLSQPVAAVYFNAQRETAPRRRPSY*
>AT4G17190.2 |  FPS2 (FARNESYL DIPHOSPHATE SYNTHASE 2) dimethylallyltranstransferase/ geranyltranstransferase 
MDNSVTRRGQPCWFRKPKVGMIAINDGILLRNHIHRILKKHFREMPYYVDLVDLFNEVEF 
QTACGQMIDLITTFDGEKDLSKYSLQIHRRIVEYKTAYYSFYLPVACALLMAGENLENHT 
DVKTVLVDMGIYFQVQDDYLDCFADPETLGKIGTDIEDFKCSWLVVKALERCSEEQTKIL 
YENYGKAEPSNVAKVKALYKELDLEGAFMEYEKESYEKLTKLIEAHQSKAIQAVLKSFLA 
KIYKRQK*
>AT4G17190.2 |  FPS2 (FARNESYL DIPHOSPHATE SYNTHASE 2) dimethylallyltranstransferase/ geranyltranstransferase 
MDNSVTRRGQPCWFRKPKVGMIAINDGILLRNHIHRILKKHFREMPYYVDLVDLFNEVEF 
QTACGQMIDLITTFDGEKDLSKYSLQIHRRIVEYKTAYYSFYLPVACALLMAGENLENHT 
DVKTVLVDMGIYFQVQDDYLDCFADPETLGKIGTDIEDFKCSWLVVKALERCSEEQTKIL 
YENYGKAEPSNVAKVKALYKELDLEGAFMEYEKESYEKLTKLIEAHQSKAIQAVLKSFLA 
KIYKRQK*
>AT4G17190.1 |  FPS2 (FARNESYL DIPHOSPHATE SYNTHASE 2) dimethylallyltranstransferase/ geranyltranstransferase 
MADLKSTFLDVYSVLKSDLLQDPSFEFTHESRQWLERMLDYNVRGGKLNRGLSVVDSYKL 
LKQGQDLTEKETFLSCALGWCIEWLQAYFLVLDDIMDNSVTRRGQPCWFRKPKVGMIAIN 
DGILLRNHIHRILKKHFREMPYYVDLVDLFNEVEFQTACGQMIDLITTFDGEKDLSKYSL 
QIHRRIVEYKTAYYSFYLPVACALLMAGENLENHTDVKTVLVDMGIYFQVQDDYLDCFAD 
PETLGKIGTDIEDFKCSWLVVKALERCSEEQTKILYENYGKAEPSNVAKVKALYKELDLE 
GAFMEYEKESYEKLTKLIEAHQSKAIQAVLKSFLAKIYKRQK*
>AT4G17190.1 |  FPS2 (FARNESYL DIPHOSPHATE SYNTHASE 2) dimethylallyltranstransferase/ geranyltranstransferase 
MADLKSTFLDVYSVLKSDLLQDPSFEFTHESRQWLERMLDYNVRGGKLNRGLSVVDSYKL 
LKQGQDLTEKETFLSCALGWCIEWLQAYFLVLDDIMDNSVTRRGQPCWFRKPKVGMIAIN 
DGILLRNHIHRILKKHFREMPYYVDLVDLFNEVEFQTACGQMIDLITTFDGEKDLSKYSL 
QIHRRIVEYKTAYYSFYLPVACALLMAGENLENHTDVKTVLVDMGIYFQVQDDYLDCFAD 
PETLGKIGTDIEDFKCSWLVVKALERCSEEQTKILYENYGKAEPSNVAKVKALYKELDLE 
GAFMEYEKESYEKLTKLIEAHQSKAIQAVLKSFLAKIYKRQK*
>AT2G16740.1 |  UBC29 (ubiquitin-conjugating enzyme 29) ubiquitin-protein ligase 
MATRRILKELKELQRDPPVSCSAGPTGEDMFHWQATIMGPNESPYSGGVFLVNIHFPPDY 
PFKPPKVVFRTKVFHPNINSNGNICLDILKDQWSPALTISKVLLSICSLLTDPNPDDPLV 
PEIAHIYKTDKTKYEAMARSWTQKYALF*
>AT1G78290.2 |  serine/threonine protein kinase putative 
MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 
IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 
HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 
ADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRI 
FVANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMMNGPSTQTVEEIVWIIEEARKPITVA 
TGLAGAGGSGGSSNGAIGSSSMDLDDLDTDFDDIDTADLLSPL*
>AT1G78290.2 |  serine/threonine protein kinase putative 
MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 
IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 
HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 
ADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRI 
FVANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMMNGPSTQTVEEIVWIIEEARKPITVA 
TGLAGAGGSGGSSNGAIGSSSMDLDDLDTDFDDIDTADLLSPL*
>AT1G78290.3 |  serine/threonine protein kinase putative 
MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 
IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 
HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 
ADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRI 
FVANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMMNGPSTQTVEEIVWIIEEARKPITVA 
TGLAGAGGSGGSSNGAIGSSSMDLDDLDTDFDDIDTADLLSPL*
>AT1G78290.3 |  serine/threonine protein kinase putative 
MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 
IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 
HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 
ADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRI 
FVANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMMNGPSTQTVEEIVWIIEEARKPITVA 
TGLAGAGGSGGSSNGAIGSSSMDLDDLDTDFDDIDTADLLSPL*
>AT2G43360.1 |  BIO2 (BIOTIN AUXOTROPH 2) biotin synthase 
MMLVRSVFRSQLRPSVSGGLQSASCYSSLSAASAEAERTIREGPRNDWSRDEIKSVYDSP 
LLDLLFHGAQVHRHVHNFREVQQCTLLSIKTGGCSEDCSYCPQSSRYSTGVKAQRLMSKD 
AVIDAAKKAKEAGSTRFCMGAAWRDTIGRKTNFSQILEYIKEIRGMGMEVCCTLGMIEKQ 
QALELKKAGLTAYNHNLDTSREYYPNVITTRSYDDRLETLSHVRDAGINVCSGGIIGLGE 
AEEDRIGLLHTLATLPSHPESVPINALLAVKGTPLEDQKPVEIWEMIRMIGTARIVMPKA 
MVRLSAGRVRFSMSEQALCFLAGANSIFTGEKLLTTPNNDFDADQLMFKTLGLIPKPPSF 
SEDDSESENCEKVASASH*
>AT3G53730.1 |  histone H4 
MSGRGKGGKGLGKGGAKRHRKVLRDNIQGITKPAIRRLARRGGVKRISGLIYEETRGVLK 
IFLENVIRDAVTYTEHARRKTVTAMDVVYALKRQGRTLYGFGG*
>AT2G41530.1 |  SFGH (S-FORMYLGLUTATHIONE HYDROLASE) S-formylglutathione hydrolase/ hydrolase acting on ester bonds 
MASGLSEIGSTKMFDGYNKRYKHFSETLGCSMTFSIYFPPSASSSHKSPVLYWLSGLTCT 
DENFIIKSGAQRAASTHGIALVAPDTSPRGLNVEGEADSYDFGVGAGFYLNATQEKWKNW 
RMYDYVVKELPKLLSENFSQLDTTKASISGHSMGGHGALTIYLRNLDKYKSVSAFAPITN 
PINCAWGQKAFTNYLGDNKAAWEEYDATCLISKYNNLSATILIDQGENDQFYPDQLLPSK 
FEEACKKVNAPLLLRLHPGYDHSYYFIATFIEDHISHHAQALEL*
>AT3G19190.1 |  FUNCTIONS IN molecular_function unknown INVOLVED IN biological_process unknown LOCATED IN cellular_component unknown EXPRESSED IN 22 plant structures EXPRESSED DURING 13 growth stages CONTAINS InterPro DOMAIN/s ATG2 C-terminal (InterProIPR015412) Has 603 Blast hits to 514 proteins in 156 species Archae - 0 Bacteria - 19 Metazoa - 326 Fungi - 168 Plants - 38 Viruses - 0 Other Eukaryotes - 52 (source NCBI BLink) 
MVFPWNIAKSAEEAFSRWAVKRVVKFLLKKKLGKLILGDIDLDQLDIQLRDGTIQLSDLA 
INVDYLNDKFDAPLVIKEGSIGSLLVKMPWKTNGCQVEVDELELVLAPRLESNKSSSNEA 
STSASTREDLHNIRLEIGKHENEMLMNAAKSASIDVHEGVKTVAKIVKWFLTSFHVKIKN 
LIIAFDPDFGKKQSEAGPRPTLVLRMTEIECGISEEQVSANEVSPDNFLGINRLANCVKF 
QGAVVELLNMDDDDDGDKTCDKKTSNDVTLIMTGVGGGFSGSLNFSIPWKNGSLDIRKVD 
ADISIDPVEVRFQPSTIRWFLQLWKTFTSFGSDCFPSVSHSDFLTDSPTIPTNVMVTPPA 
TLSLSGGQELEHDTTPNLQFIPDWFPSSFSKKEEDGEVDIGASVDQFFECFDAMRSYQSA 
SGSQGMWNWTSSVFTAINAASSLASGSLLLPSEQQHVETSCKVSFAGVSVVLFFQDEVNW 
KGVSTRIHYLGAELRDISVSFQVCLHDLRLEGEVNSMEIADYCQGGNVVDTANAESQTCL 
IKDLQAKVQTSLPPFASSDMHSDSERLSEIVSDGFLFRNKGFAVKTLLVIAAGGSGFQFT 
VNFQSSKASHRGSNSFSLSLPPTTFWLNLHSVEMLVNLFNDVSESIPITSHERNQVASSS 
KSESLRGSVSICNARVILWFPFESISERFCNSLGQQFIVVDLSSSPPSDKERAKERSPGE 
MHFPSATRSICFSVGDASIYLVTSDLKDSETNSYHRQVEFSAYNILHTNNKTRHQLSTIG 
MFWQDRPTVSPWLVERAKMLATQEESIQTDKSGGRGLEFAAVATPKDQDDIYSRSRKEII 
LASSFCLYVHLLPLAIHLDSWQYSKLCNLIEEAKNWLSRMAANTAEQTEESVVCQTSLVV 
DCDSIDILVRPEPRMGIKKQLQTELPGSWIQFNLRVQKLNLMSVPNLGSVSGADFFWLAH 
GEGTLLGSVTGLPDQELLLLSCNNSAIKRGNGGGSNALSSRFAGLDFLHLQEPGICNDYL 
AVSARGCTISAVGGRLDWIEVATSFFSFEDEKKTQEINSSSSSGSSFILNFVDVGLSYEP 
HHENTDHLRQASDPWVACLVAASSFSLSKKSLVDSIRNDYRIRIQDLGLLLSVDFDLSKL 
GGTYSSEHLHESGYVKVANDSLIEAILRTNSENGLLWELECSKSHLVIETCSDTTSGLIR 
LATQLQQLLAPDLEESAVHLQTRWDSIQQANARNDLDISDRLSSSDSSGEMKYLRLESEN 
ETGVIGLMDEINEDAFQFDVNPTYQSDSVECQNNYMSPHGISHGQAYNWVPATEKLPSNQ 
SICGSSSRINSESSQVFLERESLPEIFENYCLSEFRPSSEVPQEGDSSGRELFPETDLRR 
GNSGWYDDASLRIVEDHVSEATEEDHEEHILDGECSSFGQTSYSAVAANGRILLKNIDLK 
WRIYSGSDWHDSRKKGENFKHTKGRDTTSCLELELSGVLGYYNSKDHPRDSSSYAFKLEL 
KAVRPDPETPLEENRFFGANSLEKPVVSMGDSGGSTMSVSVQGHNIIEEALLPYFQKFDI 
WPVNVRVDYSPHHVDIAALTGGKYAELVNLVPWKHNLLITEEQMQGIELQLKHVHAAGIY 
GWGNVCETILGEWLEDVSQNQIHQLLKGIPTVRSLSALYAAALKLVSSPVESYRKDRRLV 
KGVQRGTVAFLRSISLEAVGLGVHLAAGAHDILLRAEYIFASSPSLPQPQGRTKTNVRHN 
QPRNAKQGMLKACESIGDGIGKTASALVRTPLKKYQRGDGAGSAFATVVQGVPTAAIAPA 
SACARAVHSALVGIRNRSVHIKYFGNTAGNICYLQSIKDSCRLFLLSVLILNIKRNPWKN 
T*
>AT4G09200.1 |  SPla/RYanodine receptor (SPRY) domain-containing protein 
MEENEEEEELRPTALYTVGGSDEFTFVSPDGLSGQYTGPDHDGVVLQTENPAPTNCLAYY 
FEVHIMNAGEKGEIAIGFSKEHIYSEGYTVRSCAYIGNSGLICSQNGDGDRTVAKASDTY 
TTGDLVGCGIDSVSQEFFFTKNGTIVGTIPRQFRRPVYPTIVLHSQNEAVTVNFGGQIAF 
SFDFEHFEESLRVKKEREIEKISMSRSISHGLVKTYLLRYGYEDSFRAFNLAASRHTVIA 
QENSFDEYELHQRKKLRELIMTAEIDDAIAALKDRYPQLIEGGSEAYFLLICQKIVELVR 
KGAIAEAKSFGNQDFKDFRDSSLLKNLFDDCSALFECETIEESGAAYLLGETQKNIVAAA 
VSEAILSTNPATRDQQSASLERVLRQFEATCSLYARE*
>AT4G35620.1 |  CYCB22 (Cyclin B22) cyclin-dependent protein kinase regulator 
MVNPEENNRNLVVKPITEILQDDDKRSRKFGVEMKRQNRRALGVINHNLVGAKAYPCVVN 
KRRGLSQRKQESCDKKKLDSLHPSISRSQEETKKLKPSGNEFGDCIFIDEEEEKNEEVTL 
DQPMPMSLEEPYIEFDPMEEEVEMEDMEEEQEEPVLDIDEYDANNSLAAVEYVQDLYDFY 
RKTERFSCVPLDYMAQQFDISDKMRAILIDWLIEVHDKFELMNETLFLTVNLIDRFLSKQ 
AVARKKLQLVGLVALLLACKYEEVSVPIVEDLVVISDKAYTRTDVLEMEKIMLSTLQFNM 
SLPTQYPFLKRFLKAAQSDKKLEILASFLIELALVDYEMVRYPPSLLAATAVYTAQCTIH 
GFSEWNSTCEFHCHYSENQLLECCRRMVRLHQKAGTDKLTGVHRKYSSSKFGYIATKYEA 
AHFLVSDSH*
>AT5G17000.1 |  NADP-dependent oxidoreductase putative 
MTATNKQVVLKNYVSGFPKESDFDFKTTTVEFKLPGGSNSVLVKNLYLSCDPYMRIRMGK 
PDPSTAALAQAYAPGKPIFGYGVSRVIESGHPDYKKGDLLWGIVGWEEYSVITPMTHMHF 
KIQHTDIPLSYYTGLLGMPGMTAYAGFYEVCSPKEGETVYVSAASGAVGQLVGQFAKMMG 
CYVVGSAGSTEKVDLLKTKFGFDDAFNYKEEPDLSAALKRCFPTGIDIYFENVGGKMLDA 
VLLNMNPHGRIAVCGMISQYNLENQEGVHNLSNIIYKRIRIQGFAVFDFYEKYSKFLDFV 
LPHIKEGKITYVEDVADGLEKGPEALVGLFHGKNVGKQVVVIARE*